5.04
price down icon2.89%   -0.15
after-market After Hours: 5.04
loading
Neuphoria Therapeutics Inc stock is traded at $5.04, with a volume of 3,481. It is down -2.89% in the last 24 hours and down -8.70% over the past month. Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
See More
Previous Close:
$5.19
Open:
$5.2001
24h Volume:
3,481
Relative Volume:
0.01
Market Cap:
$9.14M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.93%
1M Performance:
-8.70%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
Value
$5.04
$5.2001
1-Week Range:
Value
$5.02
$5.39
52-Week Range:
Value
$2.90
$12.55

Neuphoria Therapeutics Inc Stock (NEUP) Company Profile

Name
Name
Neuphoria Therapeutics Inc
Name
Phone
61 8 8150 7400
Name
Address
200 GREENHILL ROAD, EASTWOOD SA
Name
Employee
24
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
NEUP's Discussions on Twitter

Compare NEUP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NEUP
Neuphoria Therapeutics Inc
5.04 9.14M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-28-23 Upgrade H.C. Wainwright Neutral → Buy
Sep-28-23 Reiterated Maxim Group Buy
Jan-10-22 Initiated Berenberg Buy
Jan-10-22 Initiated Cantor Fitzgerald Overweight
Jan-10-22 Initiated Evercore ISI Outperform
Jan-10-22 Initiated H.C. Wainwright Buy
View All

Neuphoria Therapeutics Inc Stock (NEUP) Latest News

pulisher
Apr 16, 2025

Neuphoria Therapeutics (NEUP) Outlines Robust 2025 Drug Developm - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

Neuphoria Therapeutics IncMerck Pays $15M Milestone, Extends Cash Runway To Q3 2026 - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans - GlobeNewswire

Apr 15, 2025
pulisher
Apr 07, 2025

Neuphoria receives $15M milestone payment from Merck - MSN

Apr 07, 2025
pulisher
Mar 03, 2025

Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025 - GlobeNewswire

Mar 03, 2025
pulisher
Mar 03, 2025

Neuphoria Therapeutics Inc Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Neuphoria Therapeutics Inc Rings the Opening Bell - Nasdaq

Mar 03, 2025
pulisher
Feb 26, 2025

Neuphoria Stock Jumps On Triggering $15M Milestone Payment From Merck For Alzheimer's Study: Retail Interest Explodes - MSN

Feb 26, 2025
pulisher
Feb 23, 2025

Neuphoria Therapeutics’ Listing on Nasdaq - Global Legal Chronicle

Feb 23, 2025
pulisher
Feb 14, 2025

Neuphoria Therapeutics Inc. (NEUP) reports earnings - Quartz

Feb 14, 2025
pulisher
Feb 14, 2025

Neuphoria Therapeutics Inc. SEC 10-Q Report - TradingView

Feb 14, 2025
pulisher
Feb 12, 2025

Neuphoria Therapeutics rises on $15 mln milestone payment from Merck - TradingView

Feb 12, 2025
pulisher
Feb 12, 2025

Neuphoria Therapeutics shares surge on $15M Merck payment - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Neuphoria To Receive $15 Mln Milestone Payment From Merck; Stock Up In Pre-market - Nasdaq

Feb 12, 2025
pulisher
Feb 12, 2025

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck - GlobeNewswire

Feb 12, 2025
pulisher
Feb 12, 2025

Neuphoria Therapeutics to receive $15M milestone payment from Merck - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Neuphoria Therapeutics shares surge on $15M Merck payment By Investing.com - Investing.com Australia

Feb 12, 2025
pulisher
Feb 09, 2025

Here's Why Momentum in Neuphoria Therapeutics Inc. (NEUP) Should Keep going - MSN

Feb 09, 2025
pulisher
Feb 09, 2025

Neuphoria Therapeutics Takes the Biotech Spotlight: U.S. Relocation and Nasdaq Debut Promise Game-Changing Opportunities - Jomfruland.net

Feb 09, 2025
pulisher
Feb 07, 2025

Neuphoria Therapeutics Inc. – Common Stock (NASDAQ:NEUP) Given New $21.00 Price Target at HC Wainwright - Armenian Reporter

Feb 07, 2025
pulisher
Feb 07, 2025

Brokers Set Expectations for NEUP Q2 Earnings - Defense World

Feb 07, 2025
pulisher
Feb 06, 2025

HC Wainwright Forecasts Strong Price Appreciation for Neuphoria Therapeutics Inc. – Common Stock (NASDAQ:NEUP) Stock - Defense World

Feb 06, 2025
pulisher
Feb 06, 2025

FY2027 Earnings Estimate for NEUP Issued By HC Wainwright - Defense World

Feb 06, 2025
pulisher
Jan 28, 2025

Why Neuphoria Therapeutics Inc. (NEUP) Surged on Friday - MSN

Jan 28, 2025
pulisher
Jan 25, 2025

10 Firms Defy Market Pessimism - Insider Monkey

Jan 25, 2025
pulisher
Jan 24, 2025

Stock market news: Nvni Group +254.36%, Allurion Technologies +153.92% among top gainers during mid day trading - Business Upturn

Jan 24, 2025
pulisher
Jan 24, 2025

Stock market news: Neuphoria Therapeutics and Nvni Group saw surge of 134.96% and 245.64% concurrently during mid day trading - Business Upturn

Jan 24, 2025
pulisher
Jan 15, 2025

Neuphoria Therapeutics regains Nasdaq compliance - Investing.com India

Jan 15, 2025
pulisher
Jan 15, 2025

Neuphoria Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Australia

Jan 15, 2025
pulisher
Jan 09, 2025

Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder - Marketscreener.com

Jan 09, 2025
pulisher
Jan 09, 2025

Bionomics Trades 1.8% Lower in Premarket Activity Tuesday After Surging 46% in Previous Regular Trading Session - Marketscreener.com

Jan 09, 2025
pulisher
Jan 09, 2025

Bionomics Limited announced that it expects to receive $70 million in funding - Marketscreener.com

Jan 09, 2025
pulisher
Jan 09, 2025

Bionomics Limited to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting - Marketscreener.com

Jan 09, 2025
pulisher
Jan 09, 2025

Bionomics Limited Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder - Marketscreener.com

Jan 09, 2025
pulisher
Jan 08, 2025

NEUP (Neuphoria Therapeutics) Cash From Other Investing Act - GuruFocus.com

Jan 08, 2025
pulisher
Jan 06, 2025

NEUP (Neuphoria Therapeutics) Cash From Discontinued Investing Activities : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com

Jan 06, 2025
pulisher
Dec 27, 2024

Why Evaxion Biotech Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 27, 2024
pulisher
Dec 26, 2024

Neuphoria Therapeutics Inc. (NEUP) - Zacks Investment Research

Dec 26, 2024
pulisher
Dec 25, 2024

We're Keeping An Eye On Neuphoria Therapeutics' (NASDAQ:NEUP) Cash Burn Rate - Yahoo Finance

Dec 25, 2024
pulisher
Dec 24, 2024

Bionomics Strategic Shift with Neuphoria Redomiciliation - Yahoo Finance

Dec 24, 2024
pulisher
Dec 24, 2024

Neuphoria Therapeutics More Than Doubles After Bionomics Re-Domiciliation - MarketWatch

Dec 24, 2024
pulisher
Dec 24, 2024

NEUP Stock Price and Chart — NASDAQ:NEUP - TradingView

Dec 24, 2024
pulisher
Dec 24, 2024

Stock market news: Baosheng Media Group surged by 310.98% while Hour Loop gained 248.95% during mid day trading - Business Upturn

Dec 24, 2024

Neuphoria Therapeutics Inc Stock (NEUP) Financials Data

There is no financial data for Neuphoria Therapeutics Inc (NEUP). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Cap:     |  Volume (24h):